Biotechnology

Techseriesinsight > Blog > News > Biotechnology

February 19, 2026
Business Wire
Biotechnology, News

ENHERTU Type II Variation Validated by EMA for HER2 Positive Early Breast Cancer

The ENHERTU Type II Variation application has received validation from the European Medicines Agency (EMA) for use as a post-neoadjuvant treatment in adults with HER2 positive early breast cancer....

February 18, 2026
Business Wire
Biotechnology, News

Sensei Biotherapeutics Acquisition of Faeth and $200M Private Placement

Sensei Biotherapeutics, Inc. has completed the Sensei Biotherapeutics acquisition of Faeth Therapeutics and announced a concurrent $200 million private placement. This strategic move expands Sensei’s oncology pipeline while strengthening...

February 18, 2026
PRNewswire
Biotechnology, News

Bioiberica Wins 2025 European Innovation Award for Native Type II Collagen

Bioiberica has won the 2025 European New Product Innovation Award from Frost & Sullivan for its clinically validated Native Type II Collagen ingredient, Collavant® n2. This recognition highlights the...

February 17, 2026
Business Wire
Biotechnology, News

ImmunityBio Advances Regulatory Plans with SFDA Under Saudi-USA Biotech Alliance

ImmunityBio SFDA regulatory engagement took center stage in Riyadh as ImmunityBio met with the Saudi Food and Drug Authority (SFDA) during the Saudi-USA Biotech Alliance meeting hosted by the...

February 17, 2026
Business Wire
Biotechnology, News

Sensorion Announces CEO Transition and Interim Leadership Appointment

The Sensorion CEO transition marks a significant leadership update for Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company developing innovative therapies for hearing loss disorders. The company confirmed that...

February 16, 2026
Business Wire
Biotechnology, News

Worldwide Clinical Trials Completes Catalyst Acquisition

Worldwide Clinical Trials acquisition marks a significant expansion in the global contract research organization (CRO) landscape. Worldwide Clinical Trials has officially completed its acquisition of Catalyst Clinical Research, a...

February 16, 2026
Business Wire
Biotechnology, News

Nucleome Therapeutics Appoints Dr. Michelle Morrow as Chief Scientific Officer

Nucleome Therapeutics CSO appointment marks a significant leadership milestone as Nucleome Therapeutics names Dr. Michelle Morrow as its new Chief Scientific Officer, effective 23 February 2026. The appointment strengthens...

February 16, 2026
Business Wire
Biotechnology, News

SC Infliximab Retreatment Shows Sustained Efficacy After Drug Holiday

SC infliximab retreatment has demonstrated the ability to restore and maintain disease control in patients with inflammatory bowel disease after a treatment interruption. New findings from Celltrion, Inc. show...

February 13, 2026
PRNewswire
Biotechnology, News

HanchorBio FDA Orphan Drug Designation Boosts HCB101 for Gastric Cancer

HanchorBio has achieved a major regulatory milestone with the HanchorBio FDA orphan drug designation for HCB101. The designation supports the development of the company’s next-generation immunotherapy for gastric cancer,...

February 12, 2026
Business Wire
Biotechnology, News

EKTERLY Data: KalVista to Showcase Sebetralstat Research at AAAAI 2026

KalVista Pharmaceuticals announced it will present new EKTERLY data at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. The event will take place in Philadelphia...